Jannyl Molina, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

A Vital Journey: Blue Osa, Costa Rica

PT444 – A Glimpse Into the Psychedelic Neuroscience Landscape

Psychedelics Today Affiliate Webinar: A Course Overview and Q&A Session

The Ultimate Guide to Psychedelics in Australia

Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to...

Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares...

FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT...

Bridging Dimensions: Understanding the Mystical Experience

PT443 – Swimming in the Sacred: The Wisdom of Underground Female...

Psychedelic Bulletin #145: MAPS’ Second Phase 3 Study Published; EMA’s New...

1...444546...218 Page 45 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin